Aclaris Therapeutics所有资讯

Aclaris Therapeutics | 4：持股变动声明-高管 Monahan Joseph

01/03 18:28 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Loerop James

01/03 18:27 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Balthaser Kevin

01/03 18:27 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

01/03 18:27 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Monahan Joseph

2024/12/12 16:16 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

2024/12/06 16:22 (美东)

Aclaris Therapeutics | D：发行公告

2024/12/04 08:07 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Davis Hugh M.

2024/12/03 17:46 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

2024/12/03 16:17 (美东)

Aclaris Therapeutics | 3：首次持股声明-股东 Biosion, Inc.

2024/11/25 11:07 (美东)

Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Biosion, Inc.(9.5%)

2024/11/25 11:07 (美东)

Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Rock Springs Capital Management LP(6.32%),Rock Springs Capital LLC(6.32%)等

2024/11/22 16:06 (美东)

Aclaris Therapeutics | SC 13G：超过5%持股股东披露文件-Vivo Opportunity Fund Holdings, L.P.(7.4%),Vivo Opportunity, LLC(7.4%)等

2024/11/21 16:55 (美东)

Aclaris Therapeutics | 4：持股变动声明-董事 Mehra Anand

2024/11/20 16:23 (美东)

Aclaris Therapeutics | 3：首次持股声明-高管 Davis Hugh M.

2024/11/18 16:26 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Kenneth Griffin(0.5%),Citadel Advisors LLC(0.3%)等

2024/11/14 17:00 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

2024/11/05 16:21 (美东)

Aclaris Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Millennium Management LLC(4.2%),Millennium Group Management LLC(4.2%)等

2024/10/09 16:22 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Walker Neal

2024/10/03 16:19 (美东)

Aclaris Therapeutics | 4：持股变动声明-高管 Balthaser Kevin

2024/09/04 19:56 (美东)